Insider Profile
Michaud, Zachary
1
Companies Filed At
4
Open-Market Buys (2yr)
$14.5M
Buy Value (2yr, open-market)
Jun 23, 2025
Most Recent Trade
20
Credibility
Score
32%
Hit Rate
-0.6%
Avg 90d Return
-6.1%
Median 90d Return
31
Evaluated Trades
+25.6%
Best Trade
-21.3%
Worst Trade
Hit rate and returns are based on 31 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
25%
Hit Rate · 90d
-4.4%
Median Alpha · 90d
24
Closed Buys Evaluated
17%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
cluster buyer high frequency size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 24 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Jun 23, 2025 $CIGI
Colliers International
Exercise Sell 44,000 $88.90 $3.9M 56
Jun 23, 2025 $CIGI
Colliers International
Open Market Buy 14,000 $179.58 $2.5M 56
Jun 23, 2025 $CIGI
Colliers International
Open Market Buy 26,290 $179.75 $4.7M 56
Jun 23, 2025 $CIGI
Colliers International
Exercise Buy 44,000 $88.90 $3.9M 56
Jun 23, 2025 $CIGI
Colliers International
Exercise Sell 44,000 $88.90 $3.9M 56
Jun 23, 2025 $CIGI
Colliers International
Open Market Buy 26,290 $179.66 $4.7M 56
Jun 23, 2025 $CIGI
Colliers International
Open Market Buy 14,000 $179.58 $2.5M 56
Dec 03, 2024 $CIGI
Colliers International
Comp. Grant Buy 70,000 $151.62 $10.6M 56
Mar 14, 2024 $CIGI
Colliers International
Open Market Buy 12,700 $160.30 $2.0M 56
Mar 13, 2024 $CIGI
Colliers International
Open Market Buy 1,300 $162.46 $211K 56
Mar 12, 2024 $CIGI
Colliers International
Open Market Buy 8,000 $159.90 $1.3M 56
Mar 12, 2024 $CIGI
Colliers International
Open Market Buy 17,700 $159.81 $2.8M 56
Mar 12, 2024 $CIGI
Colliers International
Exercise Sell 40,000 $74.71 $3.0M 56
Mar 12, 2024 $CIGI
Colliers International
Exercise Buy 40,000 $74.71 $3.0M 56
Mar 12, 2024 $CIGI
Colliers International
Open Market Buy 200 $159.91 $32K 56
Mar 12, 2024 $CIGI
Colliers International
Open Market Buy 100 $159.84 $16K 56
Dec 12, 2023 $CIGI
Colliers International
Open Market Buy 37,800 $148.15 $5.6M 56
Dec 11, 2023 $CIGI
Colliers International
Exercise Sell 40,000 $68.65 $2.7M 56
Dec 11, 2023 $CIGI
Colliers International
Open Market Buy 2,200 $149.16 $328K 56
Dec 11, 2023 $CIGI
Colliers International
Exercise Buy 40,000 $68.65 $2.7M 56
Dec 05, 2023 $CIGI
Colliers International
Comp. Grant Buy 70,000 $106.98 $7.5M 56
May 26, 2023 $CIGI
Colliers International
Corp. Event Buy 1,776 56
Feb 14, 2023 $CIGI
Colliers International
Open Market Buy 20,000 $158.11 $3.2M 56
Feb 13, 2023 $CIGI
Colliers International
Exercise Buy 30,000 $67.30 $2.0M 56
Feb 13, 2023 $CIGI
Colliers International
Exercise Sell 30,000 $67.30 $2.0M 56
Mar 04, 2022 $CIGI
Colliers International
Open Market Buy 100 $155.26 $16K 56
Mar 04, 2022 $CIGI
Colliers International
Open Market Buy 200 $155.40 $31K 56
Mar 04, 2022 $CIGI
Colliers International
Open Market Buy 90 $155.41 $14K 56
Mar 04, 2022 $CIGI
Colliers International
Open Market Buy 900 $155.26 $140K 56
Mar 03, 2022 $CIGI
Colliers International
Open Market Buy 14 $161.90 $2K 56
Mar 03, 2022 $CIGI
Colliers International
Open Market Buy 1,200 $161.81 $194K 56
Mar 03, 2022 $CIGI
Colliers International
Open Market Buy 42 $161.93 $7K 56
Mar 03, 2022 $CIGI
Colliers International
Open Market Buy 300 $161.88 $49K 56
Mar 03, 2022 $CIGI
Colliers International
Open Market Buy 100 $161.83 $16K 56
Mar 03, 2022 $CIGI
Colliers International
Open Market Buy 100 $161.80 $16K 56
Mar 03, 2022 $CIGI
Colliers International
Open Market Buy 100 $161.79 $16K 56
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.